| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000023119 |
| Receipt No. | R000026625 |
| Official scientific title of the study | Extension of collagenase injection into the pretendinous cord in patients with Dupuytren contracture |
| Date of disclosure of the study information | 2016/07/11 |
| Last modified on | 2016/07/11 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Extension of collagenase injection into the pretendinous cord in patients with Dupuytren contracture | |
| Title of the study (Brief title) | Dupuytren | |
| Region |
|
|
| Condition | ||
| Condition | Dupuytren | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Purpose of this study is to investigate how far collagenase extends beyond the pretendinous cord after injection, so that we could detect risk of flexor tendon rupture. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Extension of T2 high lesion in the involved hand right after collagenase injection |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | MRI right after collagenase injection | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Dupytren contracture patients with pretendinous cord | |||
| Key exclusion criteria | Patients with history of allergic reaction to collagenase | |||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Shigeharu Uchiyama |
| Organization | Department of Orthopaedic Surgery
Shinshu University School of Medicine |
| Division name | Orthopaedic Surgery |
| Address | Asahi3-1-1 Matsumoto JAPAN |
| TEL | 0263-37-3095 |
| sigeuti@shinshu-u.ac.jp | |
| Public contact | |
| Name of contact person | Shigeharu Uchiyama |
| Organization | Department of Orthopaedic Surgery Shinshu University School of Medicine |
| Division name | Orthopaedic Surgery |
| Address | Asahi3-1-1 Matsumoto JAPAN |
| TEL | 0263-37-3095 |
| Homepage URL | |
| sigeuti@shinshu-u.ac.jp | |
| Sponsor | |
| Institute | Department of Orthopaedic Surgery Shinshu University School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Shinshu University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026625 |